Halozyme Therapeutics
Halozyme Therapeutics is an American biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004.
-
Hylenex Package: Hylenex Hyaluronidase, Human Recombinant, Preservative Free 150 Unit / mL Injection Single Dose Vial Box of 4 x 1 mL
Hylenex ® Package (Ship on Ice, Non-Returnable Package)
Package Includes:
Hylenex 150 Unit/mL 4 x 1mL (Ship on Ice, Non-Returnable Package)
Choice of Insulin Syringes:
1/3cc 31G x 5/16 Insulin Syringes, Box/100
1cc 30G x 5/16 Insulin Syringes, Box/100Choice of Gauze:
Gauze: 2 x 2 Gauze, Non-Sterile, 12-Ply, 200/PK
Gauze: 4 x 4 Sleeve, Non-Sterile, 12-Ply, 2, 200/PKSharp Container, 2 Gallon
Alcohol Prep Pads, Medium, Box/200
NOTE: The package is shipped on ICE and is non-returnable.
$379.99 -
Hylenex Injection 150 Units SDV 4 x 1mL
HYLENEX INJECTION SDV, 150U/ML (150 UNITS), 4X1ML (4 VIALS, 1mL EACH)
NDC # 01865-7117-04
SHIP IN ICE
NON-RETURNABLE$358.00
